Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Watch the full video on Radcliffe Cardiology here:

Dr Susheel Kodali (Columbia University Medical Center, New York, NY, US) discusses the six-month outcomes of the TRISCEND II Pivotal Trial. Originally presented at TCT 2021, this is a randomized multicenter controlled trial aiming to evaluate the safety and effectiveness of the EVOQUE tricuspid valve replacement system. At 6 months, the results suggest positive outcomes, with a reduction in tricuspid regurgitation recorded in the majority of patients.

Discussion Points:
- The Evoque device
- Patient recommendations
- Aims of TRISCEND II
- Key Findings
- Next Steps

Recorded remotely from New York, 2021.
Interviewer: Jordan Rance


Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.

Чтобы скачать видео "TCT 2021: TRISCEND II: 6Mo Outcomes Show TR Reduction in Majority of Patients | Dr Susheel Kodali" передвинте ползунок вправо